We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TSLA:NASDAQTesla, Inc. analysis

Data as of Oct 20, 2026 - not real-time

Latest price
$368.06
Risk: high
8/10High risk

Summary

The moving-average structure behind Tesla, Inc. is neutral at $368.06, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 3.9%. With RSI at 50.6 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $345.88 and resistance around $388.56.
Valuation screens as overvalued, on a P/E of 340.8 with no clean sector comparison available. Consensus targets land 8.1% above where the shares trade now. Revenue is growing at 25.5% on a 3.7% profit margin.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 31.5%, a beta of 2.21 and a maximum drawdown of 39.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 88 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top market events

  • Tesla Inc. stocks have been trading up by 3.22 percent after upbeat delivery forecasts boosted investor confidence in...
  • A federal appeals court has dealt a significant blow to a class action lawsuit targeting Tesla's self-driving claims,...
  • Tesla TSLA Reports Earnings Tomorrow: What To Expect

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading below the 200-day average of 387.58
  • MACD momentum is negative
  • Beta of 2.21 versus the benchmark

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading below the 200-day average of 387.58
  • Analyst targets imply +8.1% versus the current price
  • MACD momentum is negative

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Analyst targets imply +8.1% versus the current price
  • Revenue growth of +25.5%
  • P/E ratio of 340.8

Key metrics

Financial health

Revenue Growth25.50%
Profit Margin3.67%
P/E Ratio340.8
ROE4.67%
ROA1.93%
Debt/Equity18.37
P/B Ratio16.7
Op. Cash Flow$18.7B
Free Cash Flow$4.8B

Technical analysis

TrendNeutral
RSI50.6
Support$345.88
Resistance$388.56
MA 20$369.97
MA 50$360.25
MA 200$387.58
MACDBearish
VolumeDecreasing
Fear & Greed Index88.5

Valuation

Fair Value$47.26
Target Price$397.83
Upside/Downside8.09%
GradeOvervalued
TypeGrowth

Risk assessment

Beta2.21
Volatility31.47%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.